Streetbeat News

Price Targets

EWTX

RBC Capital analyst Leonid Timashev has maintained an 'Outperform' rating on Edgewise Therapeutics and increased the price target from $32 to $42.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:15 pm

VSAT

B of A Securities analyst Benjamin Haynor maintains a Buy rating on Viasat (NASDAQ:VSAT) but lowers the price target from $31 to $19.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:12 pm

VC

Wells Fargo analyst Colin Langan has upgraded Visteon (NASDAQ:VC) from Equal-Weight to Overweight and increased the price target from $115 to $122.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:11 pm

MELI

Morgan Stanley analyst Andrew Ruben has maintained an Overweight rating on MercadoLibre and raised the price target from $2175 to $2500.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:09 pm

DAN

Wells Fargo analyst Colin Langan has downgraded Dana Inc. (NYSE:DAN) from Equal-Weight to Underweight and reduced the price target from $13 to $9.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:08 pm

DRI

Morgan Stanley analyst Brian Harbour has maintained an Overweight rating on Darden Restaurants and raised the price target from $175 to $188.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:06 pm

APTV

Wells Fargo has upgraded Aptiv (NYSE:APTV) from Equal-Weight to Overweight and increased its price target from $78 to $87, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:06 pm

DPZ

Loop Capital has reiterated its Hold rating on Domino's Pizza (NYSE:DPZ) and maintained a price target of $419.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:04 pm

FDX

Evercore ISI Group has maintained an 'Outperform' rating on FedEx but lowered its price target from $335 to $318.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 1:03 pm

TRUP

Trupanion (NASDAQ:TRUP) has been analyzed by six analysts, showing a range of opinions from bullish to indifferent. The average 12-month price target has increased to $39.0, with a high of $56.00 and a low of $30.00. Recent analyst actions include several rating raises and price target increases. Despite revenue growth, Trupanion faces challenges with low net margin, ROE, and ROA compared to industry standards.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 1:00 pm